Skip to main content
GutCited

Lactobacillus plantarum के लिए Irritable Bowel Syndrome (IBS)

B

Reduces abdominal pain and bloating in IBS. Multiple RCTs show significant improvement in global IBS symptom scores. Strain-specific evidence for 299v is relatively strong.

<\/script>\n
`; }, get iframeSnippet() { const domain = 'gutcited.com'; const params = 'ingredient\u003Dlactobacillus\u002Dplantarum\u0026condition\u003Dibs'; return ``; }, get activeSnippet() { return this.method === 'script' ? this.scriptSnippet : this.iframeSnippet; }, copySnippet() { navigator.clipboard.writeText(this.activeSnippet).then(() => { this.copied = true; setTimeout(() => { this.copied = false; }, 2000); }); } }" @keydown.escape.window="open = false" @click.outside="open = false">

Embed This Widget

Style



      
      
    

Widget powered by . Free, no account required.

B

निष्कर्ष

Reduces abdominal pain and bloating in IBS. Multiple RCTs show significant improvement in global IBS symptom scores. Strain-specific evidence for 299v is relatively strong.

Key Study Findings

Meta-Analysis n=3154
Comparative effectiveness and safety of probiotics with psychotropic potential in mental health benefits in irritable …
Dose: None बनाम: placebo Outcome: quality of life, depression, and anxiety in IBS … प्रभाव: SUCRA=89.7% (B. longum for QoL); SUCRA=95.6% (probiotic combo for depression) None

जनसंख्या: patients with irritable bowel syndrome

Meta-Analysis
Strain-Specific Systematic Review with Meta-Analysis of Probiotics Efficacy in the Treatment of Irritable Bowel Syndrome.
Dose: None बनाम: placebo Outcome: improvement in key IBS symptoms प्रभाव: None None

जनसंख्या: patients with IBS from 32 RCTs evaluating 10 probiotic strains

Other n=25 4 weeks
Effect of probiotic administration of Bifidobacterium animalis subsp. lactis BB-12 and Lactiplantibacillus plantarum ATCC 14917 …
Dose: Bifidobacterium animalis subsp. lactis BB-12 and Lactiplantibacillus plantarum ATCC 14917 बनाम: phosphate-buffered saline (PBS) Outcome: visceral hypersensitivity (abdominal withdrawal reflex scores) प्रभाव: None p<0.05

जनसंख्या: female rats with water avoidance stress-induced IBS-D model

Other
Lactobacillus plantarum and Galacto-Oligosaccharides Synbiotic Relieve Irritable Bowel Syndrome by Reshaping Gut Microbiota and Attenuating …
Dose: 1e9 CFU/day + GOS 10 g/L बनाम: IBS model mice without synbiotic Outcome: IBS symptoms and colonic dysfunction प्रभाव: None <0.05

जनसंख्या: C. rodentium + WAS IBS mouse model

Other
Synergistic Modulation of the Gut-Brain-Immune Axis by a Dual Lactobacillus Combination in a Murine IBS …
Dose: None बनाम: Single-strain or vehicle control Outcome: IBS-like symptoms in zymosan-induced mouse model प्रभाव: None None

जनसंख्या: Zymosan-induced IBS mouse model

Randomized Controlled Trial n=61 12 weeks Double-blind
Four-strain probiotic exerts a positive effect on irritable bowel syndrome symptoms occurring in inflammatory bowel …
Dose: None बनाम: Placebo Outcome: IBS-SSS (100-point reduction) प्रभाव: 45% active vs 33% placebo (P=0.42) P=0.42

जनसंख्या: IBD patients with IBS symptoms in remission

Key Statistics

5

अध्ययन

800

प्रतिभागी

Positive

B

ग्रेड

Referenced Papers

Drugs 2023 21 उद्धरण
Beneficial microbes 2021 69 उद्धरण
Central-European journal of … 2020 38 उद्धरण
Foods (Basel, Switzerland) 2019 21 उद्धरण
PloS one 2012 445 उद्धरण
Polski merkuriusz lekarski … 2012 8 उद्धरण
Zeitschrift fur Gastroenterologie 2005 17 उद्धरण
Journal of clinical … 2004 205 उद्धरण
Current treatment options … 2002 5 उद्धरण

Dosage & Usage

mg = milligrams · mcg = micrograms (1,000× smaller) · IU = International Units

सामान्य रूप से उपयोग की जाने वाली खुराकें

general:
10-20 billion CFU/day
ibssupport:
10 billion CFU/day (299v strain) for 4 weeks minimum

अधिकतम सीमा: Well-tolerated up to 20 billion CFU/day in clinical trials

अनुसंधान में अध्ययन की गई खुराकें

खुराक अवधि प्रभाव N
None -- Positive 3154
None -- Positive --
Bifidobacterium animalis subsp. lactis BB-12 and Lactiplantibacillus plantarum ATCC 14917 4 weeks Positive 25
1e9 CFU/day + GOS 10 g/L -- Positive --
None -- Positive --
None 12 weeks Neutral 61
None 8 weeks Positive 1098
10 μg 6 weeks Positive 246

सेवन का सर्वोत्तम समय: On an empty stomach or before meals

Safety & Side Effects

रिपोर्ट किए गए दुष्प्रभाव

  • Mild gas and bloating during initial use
  • Occasional loose stools
  • Histamine-related symptoms in sensitive individuals (histamine-producing species)
  • Very rare: bacteremia in immunocompromised individuals

ज्ञात अंतःक्रियाएँ

  • Antibiotics (may reduce probiotic viability; space dosing 2 hours apart)
  • Immunosuppressants (theoretical risk in immunocompromised patients)
  • Histamine-intolerance medications (L. plantarum may produce biogenic amines)

सहनीय अधिकतम सेवन: Well-tolerated up to 20 billion CFU/day in clinical trials

कोई भी सप्लीमेंट शुरू करने से पहले हमेशा अपने स्वास्थ्य सेवा प्रदाता से परामर्श करें।

Frequently Asked Questions

Does Lactobacillus plantarum help with Irritable Bowel Syndrome (IBS)?
Based on 5 studies with 800 participants, there is moderate evidence from clinical studies that Lactobacillus plantarum may support Irritable Bowel Syndrome (IBS) management. Our evidence grade is B (Good Evidence).
How much Lactobacillus plantarum should I take for Irritable Bowel Syndrome (IBS)?
Studies have used various dosages. A commonly studied range is 10-20 billion CFU/day. Always consult your healthcare provider before starting any supplement regimen.
Are there side effects of Lactobacillus plantarum?
Reported side effects may include Mild gas and bloating during initial use, Occasional loose stools, Histamine-related symptoms in sensitive individuals (histamine-producing species), Very rare: bacteremia in immunocompromised individuals. Most side effects are mild and dose-dependent. Consult your doctor if you experience any adverse reactions.
How strong is the evidence for Lactobacillus plantarum and Irritable Bowel Syndrome (IBS)?
We rate the evidence as Grade B (Good Evidence). This rating is based on 5 peer-reviewed studies with 800 total participants. The overall direction of effect is positive.

Related Evidence

FDA अस्वीकरण: इन कथनों का Food and Drug Administration द्वारा मूल्यांकन नहीं किया गया है। इस वेबसाइट पर उत्पादों और जानकारी का उद्देश्य किसी बीमारी का निदान, उपचार, इलाज या रोकथाम नहीं है। प्रस्तुत साक्ष्य ग्रेड प्रकाशित पीयर-रिव्यूड अनुसंधान के हमारे विश्लेषण पर आधारित हैं और चिकित्सा सलाह नहीं हैं। कोई भी सप्लीमेंट शुरू करने से पहले हमेशा अपने स्वास्थ्य सेवा प्रदाता से परामर्श करें।